349 related articles for article (PubMed ID: 31967742)
1. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of combined Pregabalin and Celecoxib for treatment of neuropathic pain after percutaneous endoscopic lumbar discectomy].
Li Z; Zeng J; Nie H; Jiang H; Xie T; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2017 Feb; 31(2):215-221. PubMed ID: 29786256
[TBL] [Abstract][Full Text] [Related]
3. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin versus pregabalin in relieving early post-surgical neuropathic pain in patients after lumbar disc herniation surgery: a prospective clinical trial.
Dolgun H; Turkoglu E; Kertmen H; Gurer B; Yilmaz ER; Comoglu SS; Sekerci Z
Neurol Res; 2014 Dec; 36(12):1080-5. PubMed ID: 24938318
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
[TBL] [Abstract][Full Text] [Related]
8. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
10. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
[TBL] [Abstract][Full Text] [Related]
11. Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
Khan J; Alghamdi H; Anwer MM; Eliav E; Ziccardi V
J Oral Maxillofac Surg; 2016 Jun; 74(6):1120-30. PubMed ID: 26878362
[TBL] [Abstract][Full Text] [Related]
12. Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Matsuoka H; Tagami K; Ariyoshi K; Oyamada S; Kizawa Y; Inoue A; Koyama A
Jpn J Clin Oncol; 2019 May; 49(5):486-490. PubMed ID: 30793161
[TBL] [Abstract][Full Text] [Related]
13. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Preoperative Administration of Pregabalin and Duloxetine on Cognitive Functions and Pain Management After Spinal Surgery: A Randomized, Double-blind, Placebo-controlled Study.
Altiparmak B; Güzel Ç; Gümüş Demirbilek S
Clin J Pain; 2018 Dec; 34(12):1114-1120. PubMed ID: 30020088
[TBL] [Abstract][Full Text] [Related]
15. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Barohn RJ; Gajewski B; Pasnoor M; Brown A; Herbelin LL; Kimminau KS; Mudaranthakam DP; Jawdat O; Dimachkie MM; ; Iyadurai S; Stino A; Kissel J; Pascuzzi R; Brannagan T; Wicklund M; Ahmed A; Walk D; Smith G; Quan D; Heitzman D; Tobon A; Ladha S; Wolfe G; Pulley M; Hayat G; Li Y; Thaisetthawatkul P; Lewis R; Biliciler S; Sharma K; Salajegheh K; Trivedi J; Mallonee W; Burns T; Jacoby M; Bril V; Vu T; Ramchandren S; Bazant M; Austin S; Karam C; Hussain Y; Kutz C; Twydell P; Scelsa S; Kushlaf H; Wymer J; Hehir M; Kolb N; Ralph J; Barboi A; Verma N; Ahmed M; Memon A; Saperstein D; Lou JS; Swenson A; Cash T
JAMA Neurol; 2021 Jan; 78(1):68-76. PubMed ID: 32809014
[TBL] [Abstract][Full Text] [Related]
16. Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Matsuda Y; Tahara K; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Nakura M; Morita T; Yamaguchi T; Koyama A
Support Care Cancer; 2020 Jun; 28(6):2931-2939. PubMed ID: 31761974
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
Imam MZ; Kuo A; Nicholson JR; Corradini L; Smith MT
Pharmacol Rep; 2020 Oct; 72(5):1418-1425. PubMed ID: 32715433
[TBL] [Abstract][Full Text] [Related]
18. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Mittal M; Pasnoor M; Mummaneni RB; Khan S; McVey A; Saperstein D; Herbelin L; Ridings L; Wang Y; Dimachkie MM; Barohn RJ
Int J Neurosci; 2011 Sep; 121(9):521-7. PubMed ID: 21671841
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.
Plested M; Budhia S; Gabriel Z
BMC Neurol; 2010 Nov; 10():116. PubMed ID: 21092100
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the Combination of Pregabalin with Duloxetine or Amitriptyline on the Pharmacokinetics and Antiallodynic Effect During Neuropathic Pain in Rats.
Rodrigues RF; Kawano T; Placido RV; Costa LH; Podesta MHMC; Santos RS; Galdino G; Barros CM; Boralli VB
Pain Physician; 2021 Jul; 24(4):E511-E520. PubMed ID: 34213877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
